CLINICAL_TRIALS
withdrawal
· 2013-10-10
Clinical Trial Update: Nebulized Albuterol for Congestive Heart Failure Exacerbation [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 trial evaluating nebulized albuterol for congestive heart failure exacerbation has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Francisco | Conditions: Congestive Heart Failure | Phase 2, Phase 3 | Status: WITHDRAWN